Boundless Bio, Inc.
BOLD
$1.50
-$0.03-1.96%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/1/2025
-
Zacks Investment Research
4/3/2025
-
GuruFocus
4/3/2025
-
Globe Newswire
4/1/2025
-
TipRanks Financial Blog
4/1/2025
-
The Fly
3/30/2025
-
TipRanks Financial Blog
3/29/2025
-
TipRanks Financial Blog
3/27/2025
-
GuruFocus
3/27/2025
-
GuruFocus
3/27/2025
-
The Fly
3/27/2025
-
Globe Newswire
2/26/2025
-
GuruFocus
2/26/2025
-
Globe Newswire
2/17/2025
-
ETF Channel
2/3/2025
-
The Fly
2/3/2025
-
GuruFocus
2/3/2025
-
Globe Newswire
1/13/2025
-
Simply Wall St
1/9/2025
-
Zacks Investment Research
12/13/2024
-
TipRanks Financial Blog
12/13/2024
-
The Fly
12/13/2024
-
TipRanks Financial Blog
12/13/2024
-
The Fly
12/13/2024
-
FierceBiotech.com - Biotech
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 766 9912
Address
10955 Alexandria Way
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA...
more